Oct 29 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP RECEIVES POSITIVE EMA SCIENTIFIC ADVICE FOR FURTHER CLINICAL DEVELOPMENT OF EFTI IN MBC INCLUDING PHASE III
- IMMUTEP LTD - POSITIVE FEEDBACK FOR GENERAL CLINICAL DEVELOPMENT PROGRAM INCLUDING PLANNED REGISTRATIONAL PHASE III TRIAL IN METASTATIC BREAST CANCER
- IMMUTEP LTD - OTHER REGULATORY ENGAGEMENT ONGOING, INCLUDING WITH US FOOD AND DRUG ADMINISTRATION
Oct 29 (Reuters) - Immutep Ltd (IMM) : IMMUTEP RECEIVES...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.8¢ |
Change
-0.033(9.56%) |
Mkt cap ! $450.3M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 30.5¢ | $674.9K | 2.127M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 157267 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 41414 | 8 |
View Market Depth
| Last trade - 11.29am 05/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |